It Starts with Scientific Discovery
Every new treatment begins with a question.
Researchers may identify a protein, gene, or biological process that appears to play a role in a disease. For example, scientists
studying Alzheimer’s disease may investigate how certain proteins contribute to memory loss, while researchers
studying Parkinson’s disease may focus on the loss of dopamine-producing cells in the brain.
These discoveries help researchers identify potential targets for future treatments.
At this stage, scientists are asking:
- What causes the disease?
- How does it progress?
- What biological processes can be modified or slowed?
Finding answers to these questions lays the foundation for future therapies.
Laboratory Testing Comes Next
Once researchers identify a potential treatment, it undergoes extensive laboratory testing.
Scientists evaluate whether the treatment affects the intended target and whether it appears safe. Many potential therapies never move beyond this phase because they fail to demonstrate effectiveness or raise safety concerns.
Researchers also study how a treatment behaves in the body, including how it is absorbed, processed, and eliminated.
This stage helps determine whether a treatment has enough promise to justify further investigation.
Clinical Trials Bring Research to Patients
If a treatment successfully passes preclinical testing, it may move into clinical trials.
Clinical trials are carefully designed research studies involving human participants. These studies help researchers understand whether a treatment is safe, effective, and appropriate for widespread use.
Clinical trials typically occur in several phases:
Phase 1: Safety
Researchers evaluate the treatment’s safety profile and determine appropriate dosing.
Phase 2: Effectiveness
Researchers study whether the treatment works for patients with the condition being investigated while continuing to monitor safety.
Phase 3: Large-Scale Evaluation
The treatment is studied in a much larger group of participants to confirm effectiveness, compare outcomes, and identify less common side effects.
Throughout every phase, patient safety remains the top priority.
FDA Review and Approval
Before a treatment can become widely available, the data collected during clinical trials must be reviewed by the FDA.
The FDA evaluates:
- Safety data
- Clinical trial results
- Manufacturing standards
- Potential risks and benefits
Only after this extensive review process can a treatment receive approval for public use.
Even after approval, monitoring continues to ensure ongoing safety and effectiveness.
